allantoxanamide has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies
*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]
*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]
Studies (allantoxanamide) | Trials (allantoxanamide) | Recent Studies (post-2010) (allantoxanamide) | Studies (3,4-dihydroxyphenylacetic acid) | Trials (3,4-dihydroxyphenylacetic acid) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid) |
---|---|---|---|---|---|
8 | 0 | 0 | 5,410 | 38 | 591 |
Protein | Taxonomy | allantoxanamide (IC50) | 3,4-dihydroxyphenylacetic acid (IC50) |
---|---|---|---|
intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 4.17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Church, WH; Rappolt, G | 1 |
1 other study(ies) available for allantoxanamide and 3,4-dihydroxyphenylacetic acid
Article | Year |
---|---|
Nigrostriatal catecholamine metabolism in guinea pigs is altered by purine enzyme inhibition.
Topics: 3,4-Dihydroxyphenylacetic Acid; Allopurinol; Animals; Catecholamines; Corpus Striatum; Dopamine; Enzyme Inhibitors; Guinea Pigs; Injections; Male; Norepinephrine; Oxonic Acid; Substantia Nigra; Uric Acid | 1999 |